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Autoimmunity-prone BB rats demonstrate a T lymphocytopenia and abnormal T cell subset
distribution. To test whether the life span of all T cells or only of certain subsets is reduced in BB rats,
we thymectomised 8-week-old BB and PVGrats and subsequently assessed size and composition of the
T cell population over a 6-week-period. In both strains, thymectomy (Tx) was followed by a decrease in
peripheral T cell numbers, which was proportionally larger in BB rats. The decline of the Thy-1
þ recent
thymic migrant (RTM) T cell phenotypewas similar in both strains. BB rats showed a rapid preferential
loss of CD8
þ and CD45RC
þ T cells, whereas the relative loss of RT6
þ T cells was proportional to that
of all T cells and not signiﬁcantly different from that inPVGrats. Tx at 8-week did not preventdiabetes.
Tx of 4-week-old BB rats revealed essentially the same changes in peripheral T cell subset distribution
as in 8-week-old animals. However, Tx at week 4 did prevent diabetes. Since this raised the possibility
of a temporary requirement of CD8
þ T cells for the development of diabetes, we performed CD8
depletions during different pre-diabetic intervals. We found that CD8 depletion from 4 to 8 and 4 to 14
weeks, but not from 8 to 14 weeks of age prevented diabetes. We conclude that the protective effect of
early adult Tx is, at least in part, due to the rapid loss of CD8
þ T cells, and that these cells are only
required between 4 and 8 weeks of age for diabetes to develop in BB rats.
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INTRODUCTION
In the rat, different subsets of peripheral T cells can
bedistinguishedfromeachotherbytheexpressionorlackof
CD4, CD8, Thy-1 (CD90), RT6 and CD45RC. It has been
shownthatThy-1,butnotRT6andCD45RCisexpressedby
Tcells thathaverecentlyemigratedfromthethymus.These
recent thymic migrants (RTM) have been shown to lose the
expression of Thy-1 and to acquire RT6 and CD45RC
expression after a short period (,2 weeks) in the periphery
(Thiele et al., 1987; Kampinga et al., 1992, 1997;
Hosseinzadeh and Goldschneider, 1993).
InthespontaneouslydiabeticBioBreedingrat,anumberof
abnormalitieshasbeendescribedregardingtheTcellsubsets
mentioned above, and people have been trying to link these
abnormalities to the development of diabetes (Mordes et al.,
1996; Greiner et al., 2001; Mordes, 2001). These diabetes-
prone BB (DP-BB) rats are severely T lymphocytopenic in
that they demonstrate a severely reduced CD4
þ T cell
population and a virtual lack of CD8
þ T cells (Guttmann
et al., 1983; Woda et al., 1986; Colle et al., 1992; Mordes,
2001).Nevertheless,CD8
þTcellshavebeenshowntoplaya
crucial role in the development of diabetes in BB rats (Like
et al., 1986a,b; Edouard et al., 1993; Ellerman et al., 1993).
An important feature of the lymphocytopenia is the low
frequencyofRT6
þTcells(Greineretal.,1986;Borteletal.,
2001;Mordes,2001;ThieleandHaag,2001).Thesecellsare
known to play a key role in the prevention of diabetes
(Mordes et al., 1996). Diabetes-resistant BB (DR-BB) rats
that have a very low spontaneous incidence of diabetes
(,1%) and normal numbers of circulating RT6
þ Tc e l l s
developdiabetesupondepletionofthesecells(Greineretal.,
1987; Mordes et al., 1996; Mordes, 2001), whereas DP-BB
rats can be protected from diabetes by the inoculation of
RT6
þ T cells (Burstein et al., 1989; Mordes et al.,1 9 9 6 ) .
The frequency of CD45RC
þ T cells is also decreased in
DP-BB rats (Groen et al., 1989), but to a lesser degree than
RT6
þTcells(Groenetal., 1995).Inoculation ofCD45RC
þ
T cells into syngeneic athymic recipients results in
pancreatitis, and T cells bearing the CD45RC
þ phenotype
producehighlevelsofIL-2uponinvitrostimulation(Mason
andPowrie,1990; PowrieandMason,1990).IL-2is known
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1987; O’Shea et al., 2002), whereas anti-IL-2 treatment
prevents diabetes in DP-BB rats (Hahn et al.,1 9 8 7 ) .
Furthermore, absolute numbers of Thy-1
þ T cells
are reduced in BB rats, whereas frequencies of these cells
are increased (Groen et al., 1995; Mordes, 2001). The latter
ﬁnding indicates that the peripheral T cell pool of pre-
diabetic DP-BB rats is less mature than that in age matched
control rats. As in normal rats, both RT6 and CD45RC are
mainly expressed by mature Thy-1
2 T cells (Hosseinzadeh
and Goldschneider, 1993; Kampinga et al.,1 9 9 7 ) ,w ea n d
others have hypothesised that overall reduction of
percentages of RT6
þ and CD45RC
þ T cells might be a
reﬂection of this relative immaturity in that early cell death
mightwithholdTcellsintheDP-BBratfromexpressingthe
RT6 and CD45RC maturation markers (Groen et al.,1 9 8 9 ;
Crisa ´ etal.,19 93 ;S ar ka retal.,1995).Anotherpossibilityis
that T cells in the DP-BB rat do reach the Thy-1
2/RT6
þ or
Thy-1
2/CD45RC
þstages of development, but that the cells
bearing these phenotypes have a severely reduced life span,
either due to cell death or to change of phenotype.
In the present study, BB and control PVG rats were
thymectomizedto test whetherT cells in the DP-BB rat have
a reduced life expectancy in general, or whether different
T cell subsets, phenotypically deﬁned by the expression of
CD4, CD8, Thy-1, RT6 or CD45RC, have differential life
spans. Previously, we have shown that the few CD8
þ T cells
present in BB rats (Woda et al., 1986) have such a short life
span that the vast majority of these cells does not develop to
become mature Thy-1
2 T cells (Groen et al.,1 9 9 6 a , b ) .
Nevertheless, the role of these few, largely immature CD8
þ
T cells has been shown to be crucial in the development of
IDDM in BB rats, as depletionprevents diabetes (Like etal.,
1986a,b; Ellerman et al., 1993), and adoptive transfer of
disease depends on their presence (Edouard et al., 1993).
Since early adult thymectomy (Tx) has also been shown to
prevent the BB diabetic syndrome (Like et al., 1986a,b;
Sarkar et al., 1995), we wondered whether this protective
effect might lie in a rapid depletion of short-lived CD8
þ
TcellsfromtheperipheryofBBrats.Totestthis,weassessed
whether phenotypic shifts following Tx, with special
reference to CD8
þ T cells, might help us to understand this
protective effect. As our results suggested a temporary
requirement for CD8
þ T cells in the induction of IDDM,
early in the pre-diabetic period, we also performed
differential CD8 depletion protocols to test this notion. Our
results clearly indicate an association between the protective
effect of Tx and a preferential loss of CD8
þ and CD45RC
þ
T cells early in the pre-diabetic period, and an early
temporaryrequirement for CD8
þT cells in the pathogenesis
of IDDM in the BB rat.
MATERIALS AND METHODS
Rats
Male DP-BB rats were raised and kept under clean
conventional conditions at the Central Animal Facility of
the University of Groningen, The Netherlands, and
had water and food ad libitum. Original breeding stock
was provided by Organon Pharmaceutics, Oss,
The Netherlands. At the time of the study, close to
100% of our colony developed diabetes (.90% between
12 and 20 weeks of age). Male PVG rats were raised under
SPF conditions in the Central Animal Laboratory.
The University Ethical Board for Animal Studies
approved all animal experiments reported in this study.
Antibodies
The following mAb were used: NDS58 (anti-CD45
(RT7.1)) (Newton et al., 1986), MRC OX-35 (anti-CD4)
(Jefferies et al., 1985), MRC OX-8 (anti-CD8) (Brideau
et al., 1980), MRC OX-19 (anti-CD5) (Dallman et al.,
1984), MRC OX-22 (anti-CD45RC) (Spickett et al., 1983;
McCall et al., 1992), ER4 (anti-Thy-1.1) (Vaessen et al.,
1985), 3G2 (anti-RT6.1) (Fangmann et al., 1991).
Puriﬁcation and conjugation to FITC and biotin was
performed according to standard procedures. As a second
step reagent phyco-erythrin conjugated streptavidin
(Jackson Laboratories, West Grove, USA) was used.
Tx and CD8 Depletion
Tx was performed under ether anesthesia by partial
sternotomy and surgical resection. Thymi were checked
grossly for completeness immediately after the operation,
and at autopsy thymic areas were checked both grossly
and immunohistochemically. Tx and sham-Tx were
performed in PVG rats at 8 weeks and in DP-BB rats at
4, 6 and 8 weeks of age. Depletion of CD8þ T cells was
performed with 0.3mg/kg puriﬁed MRC OX-8 Mab given
i.p. twice weekly. In the ﬁrst week of each regimen, rats
were treated with three doses.
Cell Preparation, Labelling and Flow Cytometry
Blood was taken from the tail vein and buffy coats were
prepared as previously described (Groen et al., 1995).
Cervical lymph nodes (CLN) and spleens were weighed
after removal. Suspensions were obtained by exhaustively
teasing the tissue through a metal sieve and collecting the
cells in cold Ca
2þ and Mg
2þ supplemented PBS,
containing 5% newborn calf serum (Gibco BRL, Paisley,
Scotland) and 0.05% sodium azide. For labeling, each
suspension was counted on a Coulter counter (Coulter
Epics, Hialeah, USA) and brought to a concentration of
approximately 2 £ 107 cells per ml of medium. Labelling
and FCM was performed as described previously
(Groen et al., 1995).
Calculation of Absolute Numbers of T Cells and
Statistics
For determination of numbers of leukocytes per ml blood,
per spleen, and per mg of CLN, two 20ml samples of
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20ml samples of the CLN and spleen cell suspensions
described above were counted. Percentages of T cells
among leukocytes were established by ﬂow cytometry,
using the mAb combination MRC OX-19 (all T cells) plus
NDS58 (all leukocytes). From these data, absolute
numbers of T cells per unit indicated were calculated for
each individual rat. T cell population and subpopulation
sizes in rats thymectomised at 8 weeks of age were
compared with sham values at 1, 2, 4 and 6 weeks after
Tx/sham-Tx and with values obtained at day 0 (Figs. 1
and 2). At 6 weeks after Tx/sham-Tx, one thymectomised
DP-BB (TxBB) and one sham-thymectomised DP-BB
(sham-TxBB) rat was found diabetic in the last week
before sacriﬁce. Although T cell numbers and subset
distribution in these respectiverats did not appear different
from the other animals in the same group, these were
excluded from the results.
Of a small group of DP-BB and PVG rats, T cell
(sub)populationsizesweredeterminedinbloodatday0and
later at 2 or 4 weeks after Tx (n ¼ 4; for each group). This
enabled us to calculate reductions in T cell (sub)population
sizeswithinindividualDP-BBandPVGratsrelativetotheir
own day 0 values (Fig. 3). These relative individual
reductions enabled us to test whether there were signiﬁcant
differences in the extent of T cell loss between TxBB and
thymectomised PVG (TxPVG) rats, and between different
Tcellsubsets(i.e.CD4vsCD8).Asday0andpost-Txvalues
in rats examined twice were not signiﬁcantly different
from those examined only once, these results were pooled,
exceptforFig.3,withthoseofratssampledonlyatsacriﬁce.
All data are presented as means ^ SD: Statistical
analysis was performed with StatviewTM 5.12
þ (Brain-
Power Inc, Calabasa, CA), using analysis of variance
according to Scheffe. Diabetes incidences were statisti-
cally compared using the two-tailed Fisher’s exact test.
Assessment of Diabetes
BBratswereroutinelycheckedforpolyuriaandpolydypsia.
From 10 weeks ofage, BB rats were checked for glucosuria
(Glukotest, Boehringer Mannheim, Manheim, FRG) on a
regular basis, and when found postive, blood glucose levels
were checked using a Reﬂolux S haemo-gluco-meter
(Boehringer Mannheim). Rast were diagnozed as diabetic
when blood glucose levels exceeded 10mmol/l on two
consecutive days. Determination of the diabetes incidence
andTcellpoolsizeanalyseswereperformedastwoseparate
experiments using different BB rats.
RESULTS
Proportionally Large Short-lived T Cell Population in
DP-BB Rats
Figure 1A shows that in DP-BB rats thymectomised at
week-8 absolute numbers of T cells per ml blood were
signiﬁcantly decreased compared to sham and day 0
values at all time points after Tx. For PVG rats
thymectomised at week 8, the same held from 2 weeks
after Tx onward. Sham values remained unchanged as
compared to day 0 throughout the experiment. Both in
TxBB and TxPVG rats the loss of T cells occurred in the
ﬁrst 2 weeks after Tx, whereafter numbers of T cells more
or less stabilised, thus indicating that in both strains the
T cell pool consisted of a relatively short-lived and a
longer lived T cell population. When relative individual
reductions of numbers of total T cells per ml blood were
compared in TxBB and TxPVG rats sampled on day 0 and
at 2 or 4 weeks after Tx (Fig. 3), it was found that these
were signiﬁcantly larger in TxBB than in TxPVG rats on
both post-Tx time points tested.
In CLN of TxBB rats, a mean 35% decrease in
numbers of T cells per mg CLN weight was seen after
the ﬁrst week following Tx as compared to sham
values, and a mean 50% decrease as compared to day 0
values. At week-2 after Tx and later time points, the
respective reductions were approximately 50 and 60%.
Numbers of CLN T cells in TxPVG rats demonstrated
no signiﬁcant decrease at 1-week after Tx and 20 and
30% decreases as compared to sham and day 0 values,
respectively, from 2 weeks after Tx (data not shown).
Numbers of T cells per spleen were determined only at
4 and 6 weeks after Tx and showed no signiﬁcant
differences in TxPVG compared to sham-TxPVG at
4 and 6 weeks after Tx. In TxBB rats, numbers
of splenic T cells had signiﬁcantly decreased approxi-
mately 47% at 4 weeks, and 60% at 6 weeks after
Tx (data not shown).
Collectively, these ﬁndings indicate that the proportion
of short lived T cells is signiﬁcantly larger in DP-BB rats
than in PVG rats.
Loss of most CD8
1, but not CD4
1 T Cells in the First
Week after Tx in DP-BB Rats
As anticipated, the vast majority of CD8
þ T cells in TxBB
rats disappeared in the ﬁrst week after Tx (Fig. 1C). The
patternof relativeloss of CD4
þT cells was essentially that
of total T cells (Fig. 1A and B). In TxPVG rats, on the
other hand, the relative loss of CD8
þ T cells was similar to
that of CD4
þ and total T cells (Fig. 1A–C). Figure 3
conﬁrms that there was no signiﬁcant difference between
the relative individual reductions of CD4
þ, CD8
þ and
total T cells in TxPVG rats, and between that of CD4
þ
and total T cells in TxBB rats. CD8
þ T cells in TxBB rats,
on the other hand, were found to have decreased
signiﬁcantly more when compared to CD4
þ and total
T cells in TxBB rats at 2 weeks after Tx. At both 2 and 4
weeks after Tx they were signiﬁcantly more decreased
when compared to CD8
þ T cells in TxPVG rats. These
ﬁndings show that, in TxBB rats, most CD8
þ T cells have
a severely reduced peripheral life span, which is
in agreement with what we found in nonthymectomised
DP-BB rats (Groen et al., 1996a,b).
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þ T cells in CLN of TxBB rats, essentially the
same changes were observed, as was also the case for all
the subsets following below. For TxPVG rats, detailed
subset analysis of CLN T cells was only performed 1 and 2
weeks after Tx. Again, changes were not essentially
different from blood (data not shown).
Similar Decline of the Thy-1
1 T Cell Population in
TxBB and TxPVG Rats
Table I and Fig. 2A show that percentages and absolute
numbers of Thy-1
þ T cells rapidly decreased in DP-BB
and PVG rats after Tx at 8 weeks and that the relative
reductions were similar in the two strains. Statistic
comparison of relative individual reductions in DP-BB
and PVG rats sampled at day 0 and at 2 or 4 weeks after Tx
conﬁrmed that there was no signiﬁcant difference between
the two strains (Fig. 3). This is in agreement with the
notion that, like in control rats (Thiele et al., 1987;
Kampinga et al., 1992; Hosseinzadeh and Goldschneider,
1993), Thy-1 is a marker for RTM in DP-BB rats
(Groen et al., 1995) and shows that the life span of the
Thy-1
þ phenotype is similar in both strains.
In addition, our results conﬁrm earlier ﬁndings
that DP-BB rats have a relatively larger, but in absolute
size smaller Thy-1
þ T cell pool than PVG rats, and that in
FIGURE1 Numbersof Tcells,CD4
þ and CD8
þT cells in thymectomizedand sham-thymectomizedDP-BBand PVGrats. Absolutenumbers( £ 10
4)
of (A) T cells, (B)CD4
þ, and (C) CD8
þ T cells perml of peripheralblood in DP-BB and PVGrats thymectomized or sham-thymectomized at 8 weeksof
age. Numbers of rats used were 15 for day 0 and 6–8 on other time points. Bars marked with 8 or * indicate a signiﬁcant difference with day 0 or sham
values, respectively.
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Thy-1
þ T cells decreased with age (Table I, Fig. 2A)
(Groen et al., 1995).
Preferential Loss of CD45RC
1 T Cells in TxBB Rats
AsubstantialreductioninpercentagesofCD45RC
þTce ll s,
as compared to day 0 and sham values, was noted in TxBB
rats from 2 weeks after Tx onward, whereas in TxPVG rats
an immediate and persisting increase was noted (Table II).
WhenabsolutenumbersofCD45RC
þTcellswereregarded,
a reduction of approximately 50% was already seen during
the ﬁrst week after Tx in DP-BB rats, progressing to an
approximate90%reductionat2weeks andlatertimepoints
after Tx (Fig. 2B). No change in numbers of CD45RC
þ
Tcellscouldbedemonstratedinsham-TxBBratsandinboth
groups of PVG rats. Figure 3 shows that the relative
individual loss of CD45RC
þ T cells in TxBB rats was
signiﬁcantly larger than that of total T cells in TxBB rats.
These results show that CD45RC
þ T cells were preferen-
tially lost in TxBB, but not TxPVG rats.
No Preferential Loss of RT6
1 T Cells in TxBB Rats
Table III shows that in TxPVG rats, percentages of RT6
þ
T cells increased in the ﬁrst week after Tx as compared to
FIGURE 2 Numbers of Thy-1
þ, CD45RC
þ and RT6
þ T cells in thymectomised and sham-thymectomised DP-BB and PVG rats. Absolute numbers
( £ 10
4) of (A) Thy-1
þ, (B) CD45RC
þ, and (C) RT6
þ T cells perml of peripheral blood in DP-BB and PVG rats thymectomised or sham-thymectomised
at 8 weeks of age. Numbers of rats used were 15 for day 0 and 6–8 on other time points. Bars marked with 8 or * indicate a signiﬁcant difference with
day 0 or sham values, respectively.
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TxBB rats an initial increase was followed by a decrease
to a value not signiﬁcantly different from day 0. Sham
values in both strains (percentages and absolute numbers)
remained unaltered as compared to day 0 (Table III,
Fig. 2C). At week 1 after Tx, absolute numbers of RT6
þ
T cells were unchanged in TxBB and TxPVG rats. From
then on, these numbers were decreased in both strains.
Surprisingly, with respect to relative individual loss of
RT6
þ T cells at 2 and 4 weeks after Tx, no signiﬁcant
differences were noted between TxBB and TxPVG rats
(Fig. 3), which indicates that RT6
þ T cells (as a
phenotype) are not generally shorter lived in DP-BB
than in PVG rats. Furthermore, at 2 weeks after Tx there
was no difference between the relative individual loss of
RT6
þ and total T cells in TxBB rats, and at 4 weeks after
Tx the relative individual loss of RT6
þ T cells was even
signiﬁcantly less than that of total T cells (Fig. 3).
Although percentages and absolute numbers of RT6
þ
T cells before and after Tx were very low and may have
FIGURE3 Changesin peripheral bloodT cell (sub)populations after thymectomy. Peripheral bloodT cell (sub)populationsweredeterminedin DP-BB
and PVG rats at 8 weeks of age (day 0). The rats were thymectomised, and 2 or 4 weeks later these values were determined again in the same rats.
Depicted are the means ^ SD of the individual relative changes at 2 weeks (A) and 4 weeks (B) after Tx as compared to their own day 0 values. Bars
marked with 8 indicate a signiﬁcant differnce between DP-BB and PVG rats ðp , 0:01Þ: Bars marked with * or
þ indicate a signiﬁcant difference as
compared to all T cells or CD4
þ T cells within the same strain, respectively.
TABLE II T cells expressing CD45RC after thymectomy at 8 weeks
% CD45RC
+ T cells
BB rats PVG rats
Time after treatment Sham Tx Sham Tx
Day 0 24 ^ 66 6 ^ 2
1 week 19 ^ 22 0 ^ 37 1 ^ 28 3 ^ 6
*,**
2 week 16 ^ 15 ^ 1
*,** 76 ^ 4
* 86 ^ 2
*,**
4 week 26 ^ 64 ^ 1
*,** 76 ^ 3
* 83 ^ 1
*,**
6 week 23 ^ 23 ^ 0
*,** 76 ^ 2
* 84 ^ 2
*,**
*Signiﬁcantly different compared with day 0 ðp , 0:01Þ:
**Signiﬁcantly different compared with sham-Tx ðp , 0:01Þ:
TABLE I T cells expressing Thy-1 after thymectomy at 8 weeks
% Thy-1
+ T cells
BB rats PVG rats
Time after treatment Sham Tx Sham Tx
Day 0 59 ^ 51 5 ^ 1
1 week 66 ^ 21 7 ^ 1
*,** 19 ^ 43 ^ 1
*,**
2 week 61 ^ 21 5 ^ 5
*,** 19 ^ 23 ^ 0
*,**
4 week 45 ^ 1
* 5 ^ 1
*,** 7 ^ 1
* 1 ^ 0
*,**
6 week 35 ^ 1
* 4 ^ 2
*,** 7 ^ 0
* 1 ^ 0
*,**
*Signiﬁcantly different compared with day 0 ðp , 0:01Þ:
**Signiﬁcantly different compared with sham-Tx ðp , 0:01Þ:
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been no preferential loss of RT6
þ T cells in TxBB rats.
Complete Protection from Diabetes by Tx at 4, but not
6 and 8 Weeks of Age
Previously, it was found that Tx at 3–5 weeks of age
protectedDP-BBratsfromtheonsetofdiabetes(Likeetal.,
1986a,b; Sarkar et al., 1995). In our study, DP-BB rats
thymectomised at 8 weeks of age (Tx8BB), however, were
not protected from diabetes (Table IV). We therefore
decidedtoalsothymectomiseDP-BBratsat4and6weeksof
age to assess whether a protective effect by Tx in
the prediabetic period might be age dependent. In Table IV
it is shown that Tx performed at 4 weeks of age (Tx4) was
protective, whereas Tx8 was not. Interestingly, Tx at
the intermediate timepoint of 6 weeks revealed an
intermediate degree of protection in that 3 out of 6 of the
animals became diabetic. Diabetic rats in the sham-Tx
groups were between 83 and 100%. These ﬁndings clearly
demonstratethatTxhastobeperformedbeforeacriticalage,
which appears to be earlier than 6 weeks, in order to fully
protect DP-BB rats from diabetes. There was no signiﬁcant
differenceinageofdiabetesonsetbetweenTxBBandsham-
TxBB rats when checked until 22 weeks (data not shown).
Protection from Diabetes by Tx is Associated with a
Preferential Loss of CD8
1 and CD45RC
1 T Cells
InTx8BBratswesawarapidandpreferentiallossofCD8
þ,
Thy-1
þ, and CD45RC
þ T cells (Figs. 1–3). We wondered
whetherpreferentialreductionofthesesubsetscouldalsobe
demonstrated in rats thymectomised at 4 weeks of age
(Tx4BB rats). Furthermore, it was assessed whether at
12 weeks of age, a time point somewhat before the onset of
diabetes, differences in subset distribution could be
demonstrated between Tx4BB and Tx8BB rats.
At 2 and 4 weeks after Tx4, DP-BB rats demonstrated a
relativedecreaseofCD8
þ,Thy-1
þ,andCD45RC
þTcellsas
comparedtoday0valuesandagematcheduntreatedDP-BB
rats, whereas percentages of RT6
þ T cells remained
unchanged (Table V). This is similar to the situation after
Tx8 (Tables I–III). At 12 weeks of age, there were also no
signiﬁcantdifferencesbetweenratsthymectomisedat4or8
weeks ofage.Thesedatasuggest a relationship betweenthe
induced reduction of one of the aforementioned T cell
subsets in a critical period shortly after 4 weeks of age and
the protective effect of Tx at 4 weeks. They also show that
subset distribution between 4 and 8 weeks of age appears to
be of greater imporatnce for the development op diabetes
than that just before the age of onset.
Temporary Requirement of CD8
1 T Cells for the
Development of Diabetes in DP-BB Rats
TheﬁndingthatrapidlossofCD8
þTcellsafter4weeks,but
not after 8 weeks of age may be associated with protection
formIDDMpromptedustostudytheeffectofCD8depletion
fromweeks4to8andfrom8to14ofage.Totestwhetherin
our setting and BB rat colony CD8 depletion would be as
effectiveasdescribedearlier(Likeetal.,1986a,b),agroupof
DP-BB rats was also treated with MRC OX-8 from weeks
4 to 14. Over the same time periods control rats were treated
with saline. Since the latter procedure did not inﬂuenced
development of disease and revealed similar incidences of
diabetes in either group, these results were pooled into one
saline group (Table VI). We conﬁrmed that CD8 depletion
from week 4 to 14 prevented diabetes (Like et al., 1986a,b).
Treatment with MRC OX-8 Mab from 4 to 8 weeks resulted
in a marked reduction of the diabetes incidence, whereas
theincidenceinthegrouptreatedfrom8to14weeksrevealed
an incidence similar to that in the saline treated group.
(Table VI). Lymphocytic insulitis, however, was present in
all rats protected from diabetes. CD4
2CD8
þ T cells were
completely absent from the blood 1 week after the ﬁrst
injection with MRC OX-8. One week after the last injection
percentages of CD8
þ T cells were similar to those in saline
treated animals (data not shown).
These results demonstrate that, for the processes
leading to disease, CD8
þ T cells are only required in the
early pre-diabetic life of DP-BB rats, whereas their
absence after 8 weeks of age does not appear to have
consequences for the development of diabetes.
DISCUSSION
Changes in the T Cell Population of Thymectomised
Rats
In the ﬁrst part of this study we investigated whether
the T lymphocytopenia in DP-BB rats is due to a general or
TABLE III T cells expressing RT6 after thymectomy at 8 weeks
%R T 6
+ T cells
BB rats PVG rats
Time after treatment Sham Tx Sham Tx
Day 0 5 ^ 17 6 ^ 3
1 week 5 ^ 11 2 ^ 2
*,** 82 ^ 48 7 ^ 3
*
2 week 7 ^ 16 ^ 08 0 ^ 28 6 ^ 2
*
4 week 7 ^ 27 ^ 18 3 ^ 18 4 ^ 1
*
6 week 9 ^ 16 ^ 18 2 ^ 18 4 ^ 4
*Signiﬁcantly different compared with day 0 ðp , 0:01Þ:
**Signiﬁcantly different compared with sham-Tx ðp , 0:01Þ:
TABLE IV Effect of thymectomy on the incidence of diabetes in
BB rats
Diabetic rats at 22 weeks
Thymectomy at Sham Tx
Week 4 5/6 0/8
*
Week 6 4/4 3/6
Week 8 5/5 8/8
**
*Signiﬁcantly different from sham (two-tailed Fisher’s exact, 95%, p ¼ 0:030).
**Signiﬁcantly different from Tx4 (two-tailed Fisher’s exact, 95%, p ¼ 0:0002).
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subsets. It was reported earlier that adult Tx segregates a
short lived, directly thymus dependent T cell population
froma longerlivedT cell population which persists without
thepresenceofathymus(Kappleretal.,1974;Berzinsetal.,
1998; Cunningham et al., 2001; Lee et al., 2001). Such
segregationbetween short and longer lived Tcells isclearly
demonstrated for the TxBB and TxPVG rats investigated in
thepresentstudy(Fig.1A).InTxBBrats,however,theshort
livedTcellpopulationwasfoundtobeproportionallylarger
than that in TxPVG rats (Fig. 3), which is likely to indicate
thatalsoinuntreatedDP-BBrats,aproportionallylargerpart
ofthe T cell populationthaninPVG ratswill beshort lived,
andwillcontributetotheTlymphocytopenia.Thisislargely
inlinewithearlierproposalsofareducedlifespanforTcells
in DP-BB rats (Like et al.,1 9 8 6 a , b ;G r o e net al.,1 9 8 9 ;
1996a,b; Sarkar et al., 1995), however, it clearly does not
hold for all T cells in these rats.
We have shown earlier, that the vast majority of CD8
þ
T cells in DP-BB rats has such a short life span that the cells
do not reach the Thy-1
2 compartment of T cell maturation
(Groen et al., 1996a,b). In the present study this was
conﬁrmedbythelossof,90%ofCD8
þTcellsinTxBBrats
within 1 week after Tx (Fig. 1C). Although the mechanism
underlyingthisseverelyreducedlifeexpectancystillremains
to be resolved, it adds to the explanation for a near total
absence of CD8
þ T cells in DP-BB rats (Woda et al., 1986).
The rapid and severe decrease of Thy-1
þ T cells after
TxinDP-BBandPVGrats(TableI,Figs.2Aand3)conﬁrms
earlier ﬁndings that Thy-1
þ T cells are RTM which
disappear rapidly after Tx (Kampinga et al.,1 9 9 2 ;
Hosseinzadeh and Goldschneider, 1993; Groen et al.,
1995). The disappearance of Thy-1
þ T cells may either be
due to maturational transformation to a Thy-1
2 phenotype,
tolossofThy-1
þTcellsbycelldeath,ortoamixtureofboth.
The earlier ﬁnding that the T cell population in DP-BB rats
already substantially decreased in size during the Thy-1
þ
stage of peripheral maturation (Groen et al.,1 9 9 6 a , b )
suggests that transition of Thy-1
þ T cells to the mature
Thy-1
2 stage of development is not as efﬁcient in DP-BB
rats as it is in control rats. Therefore, although RTM
reduction rates were found to be similar in TxBB and
TxPVG rats, kinetics may not be. We believe it reasonable
to assume that the relative contribution of early cell
death to the Tx-induced loss of Thy-1
þ T cells is larger in
DP-BB rats than it is in PVG rats. Based on their
experiments, Zadeh and Goldschneider concluded likewise
(Zadeh et al.,1 9 9 6 ) .
Similar to CD8
þ T cells, approximately 90% of
CD45RC
þ T cells was rapidly lost in TxBB, but not
TxPVG rats (Table II, Fig. 2B), probably indicating that in
untreated DP-BB rats CD45RC
þ T cells (as a phenotype)
have a short life span. Since we have earlier reported that
acquisition of CD45RC on immature Thy-1
þ T cells is not
disturbed in DP-BB rats (Groen et al., 1996a,b), the short
life span of the CD45RC
þ phenotype may be the major
contributory factor to the reduced frequency of CD45RC
þ
T cells observed in DP-BB rats. However, whether the
reduction in phenotypical CD45RC
þ T cells is caused by
actual loss of cells or change of phenotype cannot be
concluded from the present study.
Somewhat surprizingly, we found RT6
þ T cells in
TxBB rats to disappear proportionally to the reduction of
the total T cell population and to RT6
þ T cells in TxPVG
rats (Table III, Figs. 2C and 3). It appears that, once T cells
in the DP-BB rat have reached the RT6
þ stage of
development, a normal proportion of these cells remains
RT6
þ. This indicates that the RT6
þ T cell phenotype in
DP-BB rats may not have a reduced life span, but that the
low frequency of RT6
þ T cells observed in DP-BB rats is
better explained by a decreased input from the preceding
TABLE VI Effect on the incidence of diabetes in BB rats treated with
MRC OX-8 over different time periods
CD8 depletion Diabetic rats % diabetic
Saline 9/11 82
4–8 weeks 4/16
* 25
8–14 weeks 12/16 75
4–14 weeks 0/5
* 0
*Signiﬁcantly different from saline and 8–14 weeks group (two-tailed Fisher’s
exact, 95%, p # 0:01).
TABLE V T cell subset distribution in CLN of non-Tx- and Tx-BB rats from 4 to 8 weeks, and in 12 weeks old DP-BB rats thymectomized at
4 or 8 weeks
Age (week) when % of T cells expressing
Tx FACS
* CD4 CD8 Thy-1 RT6 CD45RC
–4 9 5 ^ 05 ^ 17 0 ^ 17 ^ 22 3 ^ 3
–6 9 4 ^ 15 ^ 15 5 ^ 2
** 7 ^ 21 9 ^ 3
–8 9 6 ^ 23 ^ 03 9 ^ 4
**,‡ 3 ^ 01 6 ^ 2
46 9 7 ^ 12 ^ 1
**,† 10 ^ 2
**,† 7 ^ 27 ^ 1
**,†
48 9 9 ^ 0
** 0 ^ 0
**,† 4 ^ 0
**,† 2 ^ 0
** 6 ^ 0
**,†
41 2 9 9 ^ 1
** 1 ^ 0
** 2 ^ 0
** 2 ^ 0
** 7 ^ 2
**
81 0 9 9 ^ 1
** 1 ^ 0
** 2 ^ 0
** 3 ^ 1
** 7 ^ 2
**
81 2 9 9 ^ 0
** 1 ^ 0
** 3 ^ 1
** 3 ^ 1
** 6 ^ 1
**
*n ¼ 4–5: Statistic comparison was performed within the same subset between day 0 (week4, non-Tx) and all other values.
**p , 0:01; between Tx and age-matched non-Tx rats.
†p , 0:01; between week 6 and week 8 non-Tx values.
‡p , 0:01; and between week 12 Tx4 and week 12 Tx8 values (no signiﬁcant differences).
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2 stage of development. This may be either due
to disturbed acquisition of RT6 expression on developing
T cells, or to major loss of cells in the maturational
pathway leading to RT6 expression. The latter two defects
havebeenreportedtooccurinDP-BBrats(Angelilloetal.,
1988; Groen et al., 1996a,b; Mordes, 2001; Thiele and
Haag, 2001).
Taken together, our results show that Tx-induced loss
of the short lived T cell population in DP-BB rats
is not randomly distributed among the subsets investi-
gated. Tx in DP-BB rats selectively affects the Thy-1
þ, the
CD8
þand the CD45RC
þTcell subsets,of which the latter
two were earlier found to be largely contained within the
Thy-1
þ subset. These data also suggest an inefﬁcient
transition from Thy-1
þ to Thy-1
2 T cells in DP-BB rats.
T Cell Subset Distribution and Diabetes in DP-BB Rats
In the secondpart of this study, it was assessed whether the
protective effect of Tx in DP-BB rats with respect to
the development of diabetes as demonstrated by others
(Like et al., 1986a,b; Sarkar et al., 1995) was reﬂected in
changes in the peripheral T cell subset distribution.
Prevention of diabetes by Tx (Like et al., 1986a,b;
Sarkar et al., 1995) and by CD8 depletion (Like et al.,
1986a,b; Ellerman et al., 1993), and a short lifespan for
CD8
þ T cells in BB rats (Groen et al., 1996a,b) raised the
question of whether a rapid loss of CD8
þ T cells following
Tx might be underlying the protective effect of Tx.
Indeed, CD8
þ T cells were found to die rapidly after Tx at
8 weeks. However, this could not be linked directly to a
protective effect since Tx at 8 weeks did not prevent
diabetes. As Tx at 4 weeks did prevent diabetes, while
having a similar effect on the peripheral T cell pool as
Tx at 8 weeks, we wondered whether the presence of
CD8
þ T cells might only be important with respect to the
onset of diabetes in the early pre-diabetic life of DP-BB
rats and no longer at 8 weeks of age. Our differential
CD8
þ T cell depletions clearly show that this is indeed the
case in DP-BB rats.
The reduction of CD4
þ/CD45RC
þ T cells after Tx may
also be important in the prevention of diabetes as these
cells have been reported to produce high levels of the Th1
associated cytokines IL-2 and g-IFN upon stimulation,
and to result in pancreatitis upon injection into syngeneic
nude rats (Mason and Powrie, 1990; Powrie and Mason,
1990). IL-2 has been shown to enhance islet cytotoxicity
(Pukel et al., 1987; O’Shea et al., 2002), whereas anti-IL2
treatment prevent diabetes in DP-BB rats (Hahn et al.,
1987). The possibility that CD4
þ/CD45RC
þ T cells are
essential helper/inducer T cells for the generation of
cytotoxic CD8
þ T cells cannot be excluded, and is
presently being investigated by treatment with anti-
CD45RC antibodies.
The period between 4 and 8 weeks of age clearly is a
critical period with respect to the eventual development of
diabetes in DP-BB rats. A similar critical period has been
demonstrated earlier both for the prevention of diabetes in
DP-BB rats and for the induction of diabetes in RT6
depleted diabetes-resistant (DR) BB rats (Greiner et al.,
1987; Burstein et al., 1989). These studies demonstrate
that BB rats can become diabetic even when RT6
þ T cells
are present, provided thatthey wereabsentaround4weeks
of age, and also that DR-BB rats are protected from
diabetes in the absence of RT6
þ T cells when these were
present around 4 weeks of age (Mordes et al., 1996;
Mordes, 2001). Our study adds to this knowledge the
observation that even in the virtual absence of RT6
þ
T cells (in DP-BB rats) around the age of 4 weeks, Tx or
depletion of CD8
þ T cells, when performed at that time,
can prevent disease, but less effective, or not at all, when
performed later in life. These results taken together
indicate that either removal by Tx and CD8 depletion, or
suppression by RT6
þ T cells of autoreactive CD8
þ T cells
in DP-BB rats is only effective when occurring long
before the onset of diabetes.
Why does removal of CD8
þ T cells by 4 weeks of age
result in complete prevention of diabetes, whereas
removal of these cells is less protective or not at all, at
6 and 8 weeks of age, respectively? Although we and
others (Voorbij et al., 1989; Mordes, 2001) have never
observed massive lymphocytic insulitis in DP-BB rats
under 8 weeks of age, some activated autoreactive CD8
þ
T cells may have already inﬁltrated and damaged some
of the islets at young age. Removal of such autoreactive
T cells (Like et al., 1986a,b; Ellerman et al., 1993) or
grafting of regulatory RT6
þ T cells (Burstein et al., 1989;
Mordes et al., 1996) at the right time would then prevent
initial damage and hence diabetes. We have shown earlier
that thymocyte subset distribution and reduced expression
of CD8 on pre-selection thymocytes in DP-BB rats indeed
suggest the generation of autoreactive CD8
þ T cells that
escape negative selection (Groen et al.,1996a,b). In fact, it
has been shown that thymocytes of DR-BB rats have the
potency to cause diabetes in athymic recipient rats after
RT6 depletion (Whalen et al., 1995; 2001).
Also changes in islet physiology and antigenicity
speciﬁc for the period from 4 to 8 weeks of age could
make the islets more vulnerable for immunological attack
at that stage. Rats are normally weaned between 21 and 28
days of age. This event marks a number of important
changes in the rat’s physiology. In the context of beta-cell
vulnerablity, one of the most important changes is the
switch from mother milk to solid food. It has been shown
that basic insulin levels before weaning are much lower
than afterwards (Pierzynowski et al., 1993) and, in
addition, after weaning a food challenge will result in a
beta-cell insulin response, whereas before weaning only
glucose levels will rise post-prandially, but not insulin
levels (Penicaud et al., 1991; Pierzynowski et al., 1993;
1995; Knapper et al., 1995) the enhanced insulin response
mentioned is related to protein content of the food taken
(Zetterstrom et al., 1985). Insulin secretion increases the
expressionofseveralisletcellantigens(Appeletal.,1989;
Roep et al., 1990; McCulloch et al., 1991) and beta-cells
have been shown to be more susceptible to invitro cellular
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when they are not (Ekblond et al., 1997). In addition,
numbers of lymphocytes are known to peak 2 weeks after
weaning (McCauley and Hartmann, 1984). Therefore, it is
highly likely that the beginning of the critical 4–8 weeks
window is caused by an increased beta-cell activity
(on a per-cell basis) in conjunction with increasing
numbers of (autoreactive) lymphocytes. Another change
around the time of weaning is a massive proliferation of
pancreatic cells (Johnson et al., 1980; Vidal et al., 1994).
This change may be more endogenously regulated than
food-induced, since the proliferation of pancreatic cells
has been repeatedly observed from approximately 1 week
before the food switch until 2 weeks after (Rodriguez-
Martin et al., 1996). This pancreatic mitotic activity might
also contribute to increased beta-cell vulnerability to
cellular immune destruction (Ekblond et al., 1997).
Moreover, dietary changes upon weaning may also
inﬂuence the T cell system directly. Colonization of the
gut takes place in early life (Simecka, 1998). Also
changing from mother’s milk to a regular infant formula is
associated with major changes in the spectrum of
intestinal bacteria species (Harmsen et al., 2000).
Extensive “cross-talk” between the intestinal ﬂora and
the mucosal immune system seems to exist, since Jiang
et al. (2001) have shown that the developing immune
system itself inﬂuences the establishment of the gut ﬂora.
The intestinal ﬂora therefore seem to play a key role in
establishing (mucosal) immunity and tolerance (Simecka,
1998; Hooper et al., 2001). It might be interesting to note
that both DP-BB and DR-BB rats display a limited V-b
TCR usage until around week-6, whereafter DR-BB rats,
but not DP-BB rats show a remarkable expansion
(Gold and Bellgrau, 1991). This expansion might rescue
the DR-BB rat from becoming diabetic.
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